Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

vascular Business. As previously announced, the Company completed the sale of its endovascular business to Spectranetics Corporation on May 30, 2008. This transaction included the sale of the ThromCat(R), QuickCat(TM) and SafeCross(R) products in consideration for $10 million in closing payments, an opportunity for up to an additional $14 million in various research and development and sales related milestones, as well as additional royalty payments based on future sales of the ThromCat(R) and SafeCross(R) products. The transaction included a manufacturing agreement, under which the Company will continue to manufacture the endovascular products for Spectranetics, and a research and development agreement, under which the Company will continue to perform defined development activities in pursuit of various FDA 510(k) approvals for next generation product approvals (please see the Company's news release dated May 13, 2008 for further information on the details of this transaction). The Company recognized a net loss of approximately $5.4 million (net of taxes of $2.7 million), or $0.44 per share tax-effected on the sale, which is presented within the Company's results of continuing operations for the quarter ended June 30, 2008. This loss does not include the benefit or expenses of achieving future milestones or royalties to be received under the transaction, which are expected to exceed the cost of accomplishing such milestones.

Share Repurchase Update. During the fourth quarter and the fiscal year ended June 30, 2008, the Company repurchased approximately 245,000 and 868,000 shares of its common stock, respectively for a total of $7.2 million and $24.4 million, respectively, with approximately $0.6 million remaining under the previously announced $25 million share repurchase program. On June 23, 2008, the Company announced that its board of directors had expanded its existing $25.0 million stock repurchase program, to provide for the repurchase of up to an addi
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015   PDI , ... today announced that Oakwood Healthcare in ... the winning entry in Delivering the ... who display excellence in building collaborative relationships between ... in healthcare facilities.  Oakwood Healthcare,s ...
(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... Biopharma, announced the beginning of a long-term relationship ... works on behalf of its members to provide ... “I am extremely pleased to count VGP as ... to more arthritic dog patients nationwide. Concentrating and ...
(Date:5/26/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology ... today announced that all outstanding common share purchase warrants ... their expiry on June 15, 2015, resulting in total ... "We thank our shareholders for their continued support," said ... "This exercise of warrants represents a strong vote of ...
(Date:5/26/2015)... , May 26, 2015  AbbVie (NYSE: ... that it has completed the acquisition of Pharmacyclics, ... oncology. Pharmacyclics is a leader in the hematological ... used to treat hematological cancers, a $24 billion ... combined with AbbVie,s broad late-stage oncology pipeline, has ...
Breaking Biology Technology:PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 2VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering 3Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 2Asterias Biotherapeutics Receives $11.7 Million in Proceeds from Exercise of Warrants 3AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6
... Calif., Dec. 10 DaVita Inc., a,leading provider of kidney ... (CKD), continues to push the Flu Fighters,initiative which takes place ... Influenza Week, Dec. 8 - 14. , ... The National Influenza Week kicks off ...
... Show 2008 Revenue Growth Of 23% , ... news release today, Microbix announced results for the fiscal year ... are continuing to fund Microbix Biosystems Inc.,s (TSX:MBX) late-stage pipeline ... short and long term, according to William J. Gastle, CEO ...
... ProVue Model from Aven Delivers Precision Illumination Advances , ... Ann Arbor, ... lens now is available for added precision, flexibility and comfort in engineering, ... recently by Aven, Inc. of Ann Arbor, Mich., uses a ...
Cached Biology Technology:DaVita Launches 'Flu Fighter Program' in Support of National Influenza Week 2Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 2Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 3Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009 460 LED Lights Enhance Magnifying Lamp for Assembly, Engineering, Inspection or Research 260 LED Lights Enhance Magnifying Lamp for Assembly, Engineering, Inspection or Research 3
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2
... with polygynous mating systems, reproductive success reflects phenotypic ... can include that of body size and weapon ... performance. , In a study published in the ... Lappin (Northern Arizona University) and Jerry F. Husak ...
... to unraveling the complex mechanisms in the brain that regulate ... by systems very similar to those in humans -- they ... for feeding behavior. Without these neurons, adult mice stop eating ... researchers found that absence of these neurons only influenced eating ...
... haplotypes provides insight into genetic basis of human diseaseHigh-throughput ... genetic variation which can give clues to the genetic ... genotypes, or information from the individual's two chromosomes. ... variations between individuals' DNA at the level of each ...
Cached Biology News:An essential regulator of body weight revealed 2An essential regulator of body weight revealed 3An essential regulator of body weight revealed 4California computer scientists double volume of data in NIH biotech repository 2California computer scientists double volume of data in NIH biotech repository 3California computer scientists double volume of data in NIH biotech repository 4
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... Analysis Note: Protein determined ... in 3.2 M (NH 4 ... pH 7.0 Preparation Note: Affinity ... sulfate suspension • Additives: MgCl ...
... Vana miRNA Bioarray Essentials Kit provides all the ... washing of the mir Vana miRNA Bioarrays ... labeled using Ambions mir Vana miRNA Labeling ... miRNA (Bioarray ID BA10001) that should be spiked ...
... siRNA Tracker Intracellular Localization Kit with ... forward approach to directly label and ... an efficient yet non-destructive manner, for ... and functional inhibition of target gene ...
Biology Products: